PORTIOLI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 382
EU - Europa 329
AS - Asia 226
SA - Sud America 1
Totale 938
Nazione #
US - Stati Uniti d'America 376
CN - Cina 146
IT - Italia 90
IE - Irlanda 80
SE - Svezia 71
SG - Singapore 43
FI - Finlandia 40
DE - Germania 29
TR - Turchia 27
CA - Canada 6
IN - India 6
CZ - Repubblica Ceca 5
UA - Ucraina 4
BE - Belgio 3
GB - Regno Unito 3
FR - Francia 2
CO - Colombia 1
HK - Hong Kong 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 938
Città #
Dublin 78
Chandler 76
Parma 54
Ashburn 38
Singapore 35
Dearborn 32
Izmir 27
Ann Arbor 26
Beijing 25
Nanjing 22
Shanghai 21
Boardman 15
Bremen 14
Princeton 14
Shenyang 12
Wilmington 12
Los Angeles 10
Fremont 9
Nanchang 9
Guangzhou 8
Hebei 7
Kunming 7
Hefei 6
Jinan 6
Santa Clara 6
Seattle 5
Ardea 4
Changsha 4
New York 4
Brussels 3
Helsinki 3
Houston 3
Jiaxing 3
Lido Di Camaiore 3
Montréal 3
Woodbridge 3
Ancona 2
Bologna 2
Brno 2
Falls Church 2
Fisciano 2
Florence 2
Jacksonville 2
Norwalk 2
Piacenza 2
San Mateo 2
Straubing 2
Toronto 2
Vigevano 2
Ardabil 1
Bogotá 1
Bratislava 1
Brooklyn 1
Caorso 1
Chengdu 1
Dallas 1
Des Moines 1
Fairfield 1
Fasano 1
Fidenza 1
Follo 1
Fontevivo 1
Guidonia 1
Hangzhou 1
Jinhua 1
Lanzhou 1
Manchester 1
Monmouth Junction 1
Nanning 1
Ottawa 1
Philadelphia 1
Pune 1
Quzhou 1
Redwood City 1
Rockville 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Vientiane 1
Washington 1
Wuhan 1
Xian 1
Zhengzhou 1
Totale 667
Nome #
Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools 132
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 110
AmpRGD-Functionalized Liposomes: From Targeted Delivery Vehicles to Integrated Targeted Antiangiogenic Tools 86
Merging RGD/Sunitinib Chemotypes to Unique Hybrid Constructs is Useful to Impair Tumor Angiogenesis and Melanoma Growth 70
Gold Nanoparticles Functionalized with RGD-Semipeptides: A Simple yet Highly Effective Targeting System for αVβ3 Integrins 68
cAmpRGD-functionalized Liposomes Loaded with a VEGFR Inhibitor for a Targeted and Combined Antiangiogenesis Activity 66
Novel AmpRGD/Sunitinib Dual Conjugates as Potential Modulators of Tumor Angiogenesis 65
AmpRGD/Sunitinib Dual Conjugates as Tumor Angiogenesis Modulators 63
Novel AmpRGD-Sunitinib Dual Conjugates as Potential Inhibitors of Tumor Angiogenesis 59
Synthesis of Novel c(AmpRGD)−Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis 56
Gold Nanoparticles Functionalized with cAmpRGD-Peptidomimetics: a Simple yet Highly Effective Targeting System for alphaVbeta3 Integrins 54
A novel, selective 111-In-labelled aminoproline-RGD-peptide for non-invasive tumor imaging: synthesis and preclinical evaluation 54
New 4-aminoproline-based small molecule cyclopeptidomimetics as potential modulators of α4β1 integrin 53
Novel cycloAmpRGD-Sunitinib Dual Conjugates as Potent Targeted Anti-angiogenic Tools 41
Totale 977
Categoria #
all - tutte 3.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 11 25 20 6 8 20 7 2
2020/2021118 40 5 2 8 9 10 9 9 12 0 14 0
2021/202279 1 0 1 23 0 7 3 11 1 4 3 25
2022/2023287 26 37 27 19 27 31 0 13 95 3 7 2
2023/2024112 8 6 6 1 5 26 9 8 11 8 11 13
2024/202569 3 17 19 9 21 0 0 0 0 0 0 0
Totale 977